GLAS
Price
$2.28
Change
+$0.03 (+1.33%)
Updated
Oct 29, 04:59 PM (EDT)
Capitalization
212.05M
13 days until earnings call
Intraday BUY SELL Signals
OGI
Price
$0.96
Change
-$0.00 (-0.00%)
Updated
Oct 29 closing price
Capitalization
138.46M
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GLAS vs OGI

GLAS vs OGI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GLAS vs. OGI commentary
Oct 30, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLAS is a StrongBuy and OGI is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for GLAS with price predictions
Oct 28, 2026

GLAS in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 19, 2026

GLAS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 30 of 33 cases where GLAS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Moving Average Convergence Divergence (MACD) for GLAS just turned positive on October 28, 2026. Looking at past instances where GLAS's MACD turned positive, the stock continued to rise in 26 of 36 cases over the following month. The odds of a continued upward trend are 72%.

Bearish Trend Analysis

The 50-day moving average for GLAS moved below the 200-day moving average on September 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GLAS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

The Aroon Indicator for GLAS entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.919) is normal, around the industry mean (8.801). P/E Ratio (-2.961) is within average values for comparable stocks, (-2.500). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (3.880) is also within normal values, averaging (178.797).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. GLAS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GLAS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

A.I.Advisor
a Summary for OGI with price predictions
Oct 29, 2026

OGI's RSI Oscillator climbs out of oversold territory

The RSI Indicator for OGI moved out of oversold territory on October 15, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 36 similar instances when the indicator left oversold territory. In 33 of the 36 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 26, 2026. You may want to consider a long position or call options on OGI as a result. In 73 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.

The Moving Average Convergence Divergence (MACD) for OGI just turned positive on October 20, 2026. Looking at past instances where OGI's MACD turned positive, the stock continued to rise in 40 of 45 cases over the following month. The odds of a continued upward trend are 89%.

Following a +2.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where OGI advanced for three days, in 169 of 214 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

OGI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

OGI moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OGI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

The Aroon Indicator for OGI entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.285) is normal, around the industry mean (8.542). P/E Ratio (1.572) is within average values for comparable stocks, (-1.854). Projected Growth (PEG Ratio) (0.030) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (0.650) is also within normal values, averaging (178.797).

The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. OGI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OGI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

FUNDAMENTALS RATINGS
GLAS vs OGI: Fundamental Ratings
GLAS
OGI
OUTLOOK RATING
1..100
504
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
37
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9846
PRICE GROWTH RATING
1..100
9776
P/E GROWTH RATING
1..100
697
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OGI's Valuation (37) in the null industry is in the same range as GLAS (42). This means that OGI’s stock grew similarly to GLAS’s over the last 12 months.

OGI's Profit vs Risk Rating (100) in the null industry is in the same range as GLAS (100). This means that OGI’s stock grew similarly to GLAS’s over the last 12 months.

OGI's SMR Rating (46) in the null industry is somewhat better than the same rating for GLAS (98). This means that OGI’s stock grew somewhat faster than GLAS’s over the last 12 months.

OGI's Price Growth Rating (76) in the null industry is in the same range as GLAS (97). This means that OGI’s stock grew similarly to GLAS’s over the last 12 months.

GLAS's P/E Growth Rating (6) in the null industry is significantly better than the same rating for OGI (97). This means that GLAS’s stock grew significantly faster than OGI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GLASOGI
RSI
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 1 day ago
84%
COMPARISON
Comparison
Oct 30, 2026
Stock price -- (GLAS: $2.28 vs. OGI: $0.96)
Brand notoriety: GLAS and OGI are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GLAS: 52% vs. OGI: 45%
Market capitalization -- GLAS: $212.05M vs. OGI: $138.46M
GLAS [@Pharmaceuticals: Generic] is valued at $212.05M. OGI’s [@Pharmaceuticals: Generic] market capitalization is $138.46M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLAS’s FA Score shows that 1 FA rating(s) are green while OGI’s FA Score has 0 green FA rating(s).

  • GLAS’s FA Score: 1 green, 4 red.
  • OGI’s FA Score: 0 green, 5 red.
According to our system of comparison, both GLAS and OGI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLAS’s TA Score shows that 3 TA indicator(s) are bullish while OGI’s TA Score has 5 bullish TA indicator(s).

  • GLAS’s TA Score: 3 bullish, 2 bearish.
  • OGI’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both GLAS and OGI are a good buy in the short-term.

Price Growth

GLAS (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while OGI (@Pharmaceuticals: Generic) price change was +2.55% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.24%. For the same industry, the average monthly price growth was -9.52%, and the average quarterly price growth was +5.69%.

Reported Earning Dates

GLAS is expected to report earnings on Nov 11, 2026.

OGI is expected to report earnings on Dec 15, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.24% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
GLAS
Daily Signal:
Gain/Loss:
OGI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

GLAS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLAS has been loosely correlated with TRLV. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if GLAS jumps, then TRLV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLAS
1D Price
Change %
GLAS100%
-3.85%
TRLV - GLAS
64%
Loosely correlated
-0.47%
CGC - GLAS
63%
Loosely correlated
-1.81%
TLRY - GLAS
59%
Loosely correlated
-2.89%
CRON - GLAS
52%
Loosely correlated
-0.89%
ACB - GLAS
50%
Loosely correlated
-1.69%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HCMT41.890.34
+0.82%
Direxion HCM Tactical Enhanced US ETF (HCMT)
SVAL43.230.03
+0.06%
iShares US Small Cap Value Factor ETF (SVAL)
NEAR50.050.01
+0.02%
iShares Short Duration Bond Active ETF (NEAR)
CVAR32.03N/A
N/A
Cultivar ETF (CVAR)
GASZ20.98-0.02
-0.08%
Corgi Natural Gas Power & Turbines ETF (GASZ)
Interesting Articles